Page 2 - Patrick Lin News Today

HANOVER, Md., Jan. 26, 2024 -- Processa Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy...

Take a look inside the Disney Legacy Animated Film Collection, the 100-film Blu-Ray box set, in our review and unboxing of this limited edition release.

HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Bringing Taiwan to the World and the World to Taiwan

Hanover, MD., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announced today with great sadness that Virgil Thompson,...

HANOVER, MD, Oct. 13, 2023 -- Processa Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy...

At MIT’s Media Lab, an engineer and biophysicist — and double amputee — is designing prosthetics that connect body and brain.

Interim analysis of Phase 1B data suggests Processa’s novel chemotherapy treatment could improve safety and efficacy in more patients by individualizing the dosing regimen for each patient ...

Liu Yongfeng, vice president of the First Hospital of China Medical University (CMU), died on Monday. Liu and ...

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […]